Objectives: To determine rates of carriage of fluoroquinolone-resistant Escherichia coli and extraintestinal pathogenic E. coli (ExPEC) among dogs in a specialist referral hospital and to examine the population structure of the isolates.
Introduction
Extraintestinal pathogenic Escherichia coli (ExPEC) often express specific virulence factors enabling them to cause extraintestinal disease, particularly urinary tract infections (UTIs), in both humans and dogs. 1 In addition, the E. coli phylogenetic group corresponds with virulence, 2 with virulent ExPEC strains generally belonging to group B2 and to a lesser extent group D.
3 Dog faeces can be a reservoir of ExPEC strains. 4 Furthermore, ExPEC strains can be shared between humans and dogs in both veterinary hospital 5 and household settings. 6 Additionally, ExPEC strains of the pandemic human UTI-and sepsis-causing B2-O25b-ST131 clonal group have been isolated recently from companion animals. 7, 8 Here we investigated fluoroquinolone-resistant faecal E. coli carriage in dogs hospitalized in a major veterinary referral hospital in Sydney, New South Wales (NSW), and determined whether such strains qualify as ExPEC based on their phylogenetic group and virulence gene (VG) content. Additionally we assessed the O25b-ST131 status of group B2 fluoroquinolone-resistant canine faecal E. coli isolates and their genetic similarity to canine clinical ST131 isolates.
Materials and methods

Isolation of fluoroquinolone-resistant E. coli from dog faeces
The study was performed according to the animal ethics guidelines of the University of Sydney (animal ethics number N00/10-2008/2/4932). Faecal samples were collected from 123 hospitalized dogs (.1 overnight stay) over a 140 day period beginning 30 March 2009. Data regarding the hospitalization period prior to sample collection, reason for admission and antimicrobial treatments at the time of sampling were provided by the hospital.
Presumptive fluoroquinolone-resistant (i.e. ciprofloxacin MIC ≥2 mg/ L) E. coli were obtained by direct inoculation of 100 mL of a 100 g/L faecal suspension in saline (containing ,2×10
8 total E. coli cfu) onto MacConkey agar (MAC) containing 2 mg/L ciprofloxacin, followed by serial dilution with drop counts onto MAC, MAC containing 2 mg/L ciprofloxacin and MAC containing 2 mg/L pradofloxacin for samples yielding fluoroquinolone-resistant colonies. Hydrophobic grid membrane filter analysis (FiltaFlex Ltd, Ontario, Canada) was performed on samples with a ratio of .0.5% fluoroquinolone-resistant E. coli cfu compared with the total coliform cfu count. Serial dilution of the faecal suspension to obtain 200-300 cfu on the master grid was followed by replication onto MAC 2 mg/L ciprofloxacin or MAC 2 mg/L pradofloxacin plates to determine the proportion of resistant organisms. Up to six colonies were picked at random from each of the resulting fluoroquinolone-containing plates for further analysis.
E. coli phylogenetic grouping and random amplified polymorphic DNA (RAPD) profiling Species identity was confirmed by detection of the E. coli-specific uspA gene. 9 The major E. coli phylogenetic group (A, B1, B2 or D) was determined by triplex PCR. 10 Fluoroquinolone-resistant E. coli isolates underwent RAPD analysis using primer 1254, 11 plus primer 1290 12 for group B2 isolates.
Virulence genotyping
VGs (n¼33) were detected by multiplex PCR as described previously, 13, 14 except for iutA primers (F: 5 ′ AGCCGACAACTGGACTCTGT 3 ′ and R: 5 ′ CCTGAGCCAGATCGAAGAAC 3 ′ ), which were developed here. Isolates were operationally defined as ExPEC if they contained ≥2 papA and/or papC, sfa/focDE, afa/dra, iutA and kpsMT II. 15 
Comparison with canine extraintestinal clinical isolates
For comparison, 14 canine phylogenetic group B2 E. coli clinical isolates were included in the RAPD analysis and virulence genotyping. 7, 16 Eleven were ciprofloxacin resistant and nine were O25b-ST131.
Determination of ST131 status and fluoroquinolone MICs
ST131-specific single nucleotide polymorphisms (SNPs) in mdh and gyrB 17 and the ST131-associated O25b rfb variant were detected by PCR. 18 Broth microdilution MICs of ciprofloxacin and pradofloxacin were determined for the group B2 isolates.
19
Statistical analysis
For isolates exhibiting .95% similarity, representative isolates (one per VG profile per dog) were selected for RAPD dendrogram construction, according to the unweighted pair group method with arithmetic mean (UPGMA) based on Pearson correlation coefficients using BioNumerics, v6.6 (Applied Maths, Kortrijk, Belgium). Fisher's exact test for two-group prevalence comparisons and the Mann-Whitney U-test for VG number comparisons were performed using PASW Statistics 17.0.3 (SPSS, Inc., Chicago, IL, USA).
Results
Prevalence, phylogenetic groups and RAPD profiles
A total of 232 fluoroquinolone-resistant faecal E. coli isolates were obtained from 23 (18.7%) of the 123 sampled dogs. Of these 23 dogs, 10 (43%) had only group D, 6 (26%) had only group A and 2 (9%) had only group B2 E. coli isolates among the studied colonies. In contrast, one (4%) had groups A plus B1, three (13%) had groups A plus D and one (4%) had groups A, B1 and D.
The RAPD 1254 dendrogram grouped the 60 representative isolates into four major clusters (I -IV, Figure 1 ). All phylogenetic group A (n¼ 25) and B1 isolates (n¼ 3) formed multiple subgroups within cluster II. Phylogenetic group B2 isolates (n¼ 5) constituted cluster III. Phylogenetic group D isolates formed three distinct clusters: cluster I (n¼ 16), a subgroup within cluster II (n¼ 2) and cluster IV (n¼ 9). For different dogs within each cluster, the time interval between the first and last E. coli isolation date for isolates exhibiting .95% RAPD similarity varied between 6 and 55 days (median 19 days).
VGs
The VG content differed significantly by phylogenetic group (Table 1) . Group B2 and D isolates contained the highest number of VGs (median 14 and 12.5, respectively). A total of 24 VG profiles were identified. Only one of the three group B2-associated VG profiles qualified as ExPEC. In contrast, most group D-associated VG profiles (16/18; 88.9%) qualified as ExPEC.
All except one of the group D isolates in cluster I shared 11 VGs in common. The second group D cluster (IV) isolates contained significantly more VGs than cluster I isolates (median 14 versus 11, P,0.001) and shared 12 -14 VG profiles with group B2 isolates ( Figure 1 ). In addition, 2 (11%) of 19 group A isolates contained 16 and 15 VGs, respectively, and qualified as ExPEC.
Comparison of faecal versus extraintestinal canine group B2 isolates
Five representative group B2 faecal isolates from two dogs belonged to ST131. In the RAPD 1254 dendrogram, four of the five faecal isolates shared 93% profile similarity with the clinical ST131 isolates (Figure 1b Influence of antimicrobial therapy on fluoroquinolone-resistant E. coli prevalence
The 44 dogs that were receiving antimicrobial treatment when sampled (53% received amoxicillin/clavulanic acid and 36% received a first-generation cephalosporin) did not differ significantly Guo et al. Guo et al. VGs tested. Pool 1: malX, pathogenicity-associated island marker; afa/draB, afimbrial/dr antigen-specific adhesin; neuC, K1 capsular polysaccharide; iha, iron-regulated-gene-homologue adhesin; hra, heat-resistant agglutinin; fimC, type 1 fimbriae (D-mannose-specific adhesin); pic, serine protease autotransporter; hlyA, haemolysin A; kpsMT II, group II capsule antigens; Pool 2: sitD ep., episomal Salmonella putative permease gene; ompA, outer membrane protein (resistant to environmental stresses; receptor of colicin and several phages); iroN, catecholate siderophore (salmochelin) receptor; sitD chr., chromosomal Salmonella putative permease gene; traT, surface exclusion protein (serum survival factor); ibeA, invasion of brain endothelium; chuA, haem receptor gene (haem uptake); Pool 3: vat, vacuolating autotransporter toxin; tsh, temperature-sensitive haemagglutinin; iucD, aerobactin synthesis; cvi/cva, structural genes of colicin V operon (microcin ColV); papC, pilus associated with pyelonephritis; sfa/focDE, sfa S fimbriae and foc F1C fimbriae; iss, increased serum survival; crlA, curli fibre gene; astA, EAST1 heat-stable cytotoxin associated with enteroaggregative E. coli; Pool 4: mat, meningitis-associated and temperature-regulated fimbriae; iutA, ferric aerobactin receptor (iron uptake/ transport); fyuA, ferric yersiniabactin uptake (yersiniabactin receptor); sat, secreted autotransporter toxin; tia, toxigenic invasion locus in ETEC strains; cnf1/2, cytotoxic necrotizing factor; ireA, iron-responsive element-putative catecholate siderophore receptor; irp2, iron-repressible protein-yersiniabactin synthesis.
a
The 43 representative isolates selected represented one VG profile per dog.
b P values for comparisons of trait prevalence across the four phylogenetic groups (Fisher's exact test) are shown where P, 0.05. c ExPEC, defined by the presence of at least two of the genes papA and/or papC (counted as one), sfa/focDE, afa/dra, iutA and kpsMT II.
Fluoroquinolone-resistant ExPEC in dogs
included pradofloxacin in our screen because it is a thirdgeneration, dual-targeting fluoroquinolone developed for the companion animal veterinary market. 20 The study yielded four major findings.
First, a high proportion of hospitalized dogs (18.7%) carried faecal fluoroquinolone-resistant E. coli. Second, different dogs were colonized with highly similar fluoroquinolone-resistant ExPEC strains, according to RAPD profiling and virulence genotyping, suggesting a potential common source of acquisition outside the hospital and/or within-hospital transmission. Third, most fluoroquinolone-resistant E. coli belonged to clonally related lineages of high inferred extraintestinal virulence potential from phylogenetic groups B2 and D. Fourth, further characterization and comparison with canine clinical extraintestinal B2 isolates from eastern Australia confirmed that all the group B2 faecal isolates belonged to the globally distributed, human-associated O25b-ST131 clonal group. Clinical and faecal ST131 isolates were closely related, according to both RAPD analysis and VG profiles.
According to RAPD analysis, closely related fluoroquinoloneresistant faecal E. coli, including ExPEC strains of presumably high virulence potential from phylogenetic group B2 and D, were shared among multiple hospitalized dogs, some of which may have already been carrying fluoroquinolone-resistant strains upon hospital admission. Some isolates were recovered within the first 24 h of admission-evidence that they were most probably acquired prior to admission. However, once hospitalized, colonized dogs, in combination with hospital staff and students, may aid in disseminating strains among convalescent animals. For example, closely related fluoroquinolone-resistant group D ExPEC in cluster IV from dogs 01-116 through 01-120 were obtained over just 19 days, suggesting possible nosocomial transmission.
Five clinical ST131 isolates (QUC 001, 004, 008, 009 and 010) were previously identified as representing human-associated PFGE pulsotype 968, which is the most prevalent ST131 pulsotype in North America and in our previous study represented 23% of Australian ST131 clinical isolates from both humans and animals. 16 Highly similar ST131 isolates from both faeces and clinical infections in dogs suggest widespread movement of ST131 subclones between dogs within Australia.
A large proportion (60.9%) of dogs colonized with fluoroquinolone-resistant E. coli carried group D-associated strains, which were distributed into three distinct RAPD clusters. Nearly all of these isolates qualified molecularly as ExPEC. 15 Each cluster was shared among multiple dogs and contained a considerable array of VGs, suggesting possible faecal -oral transmission among hospitalized dogs of resistant ExPEC strains with considerable virulence potential. Further characterization of these isolates is currently under way.
In summary, we found that hospitalized dogs can carry faecal fluoroquinolone-resistant E. coli and ExPEC, including O25b-ST131 strains, and may assist in spreading such organisms within the hospital and across a wide geographic area. Recent antimicrobial treatment did not appear to influence the faecal carriage rate. The O25b-ST131 isolates were genetically closely related to canine clinical fluoroquinolone-resistant ST131 isolates from extraintestinal infections in dogs dispersed widely within eastern Australia. An even larger proportion of dogs carried phylogenetic group D fluoroquinolone-resistant ExPEC in their faeces. These findings have obvious potentially important public health implications for animals and humans alike.
